Literature DB >> 18194420

Simple coagulation tests improve survival prediction in patients with septic shock.

G Lissalde-Lavigne1, C Combescure, L Muller, C Bengler, A Raillard, J-Y Lefrant, J-C Gris.   

Abstract

BACKGROUND: Classic mortality prediction models in intensive care units (ICUs) are based on clinical scores, which do not contain any coagulation test (SAPS-II or SOFA scores).
OBJECTIVES: To determine whether coagulation tests can improve mortality prediction in patients with septic shock. PATIENTS AND METHODS: One hundred fifty-eight consecutive patients with septic shock entering our institution's ICU were investigated on the first day of admission, and deaths were registered during the first month.
RESULTS: Among all the coagulation tests performed, only the fibrinogen (Fg) plasma level, together with the SAPS-II score and the age, were included in our simplified mortality score [area under the receiver operating curve (AUC) 0.927, standard deviation (SD) 0.030], which was more efficient than SAPS-II and SOFA scores themselves in predicting first-week mortality, its optimized cut-off having a very high negative predictive value (NPV) [0.989; 95% confidence interval (CI) 0.967-1.000)]. A simplified score predicting first-month mortality, containing the prothrombin ratio and the antithrombin activity values in addition to the age, the hemoglobin concentration, and the SAPS-II and SOFA scores (AUC 0.889, SD 0.026), was found to be superior to the SAPS-II and SOFA scores, the optimized cut-off value having a high NPV (0.952; 95% CI 0.888-1.000).
CONCLUSIONS: In patients admitted to an ICU with septic shock, some initial coagulation test values can help identify those who will survive in the first week and then in the first month.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194420     DOI: 10.1111/j.1538-7836.2008.02895.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  8 in total

1.  The prognostic role of ThromboDynamic Index in patients with severe sepsis.

Authors:  Annalisa Boscolo; Luca Spiezia; Elena Campello; Elisabetta Maria Consolaro; Carlo Ori; Paolo Simioni
Journal:  Intern Emerg Med       Date:  2019-07-02       Impact factor: 3.397

2.  Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation.

Authors:  Paul B Massion; Pierre Peters; Didier Ledoux; Valentine Zimermann; Jean-Luc Canivet; Pierre P Massion; Pierre Damas; André Gothot
Journal:  Intensive Care Med       Date:  2012-06-27       Impact factor: 17.440

3.  Prognostic value of the International Society on Thrombosis and Haemostasis scoring system for overt disseminated intravascular coagulation in emergency department sepsis.

Authors:  Q Yin; B Liu; Y Chen; Y Zhao; C Li
Journal:  Infection       Date:  2014-02-21       Impact factor: 3.553

Review 4.  Fibrinogen concentrate in bleeding patients.

Authors:  Anne Wikkelsø; Jens Lunde; Mathias Johansen; Jakob Stensballe; Jørn Wetterslev; Ann Merete Møller; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2013-08-29

5.  Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa.

Authors:  G Milone; S Leotta; A Cupri; A L Fauci; P Spina; M Parisi; D Berritta; G Tripepi
Journal:  Bone Marrow Transplant       Date:  2014-07-07       Impact factor: 5.483

6.  Long Noncoding RNA THAP9-AS1 and TSPOAP1-AS1 Provide Potential Diagnostic Signatures for Pediatric Septic Shock.

Authors:  Yong Wu; Qigai Yin; Xiaobao Zhang; Pin Zhu; Hengfei Luan; Ying Chen
Journal:  Biomed Res Int       Date:  2020-12-01       Impact factor: 3.411

7.  Time course of soluble P-selectin and von Willebrand factor levels in trauma patients: a prospective observational study.

Authors:  Ning Tang; Shiyu Yin; Ziyong Sun; Yingying Pan
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-09-14       Impact factor: 2.953

8.  Whole-blood hypocoagulable profile correlates with a greater risk of death within 28 days in patients with severe sepsis.

Authors:  Annalisa Boscolo; Luca Spiezia; Elena Campello; Diana Bertini; Vittorio Lucchetta; Eleonora Piasentini; Alessandro De Cassai; Paolo Simioni
Journal:  Korean J Anesthesiol       Date:  2020-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.